Viewing Study NCT06056895


Ignite Creation Date: 2025-12-24 @ 2:11 PM
Ignite Modification Date: 2026-02-04 @ 1:06 AM
Study NCT ID: NCT06056895
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-16
First Post: 2023-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
Sponsor: University of Washington
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8 View
None Clinical Stage IV Merkel Cell Carcinoma AJCC v8 View
None Merkel Cell Carcinoma View
Keywords: